Suppr超能文献

CD4+CD25bright+调节性T细胞可介导长期免疫抑制肾移植受者的供体无反应性。

CD4+CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients.

作者信息

Velthuis J H L, Mol W M, Weimar W, Baan C C

机构信息

Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands.

出版信息

Am J Transplant. 2006 Dec;6(12):2955-64. doi: 10.1111/j.1600-6143.2006.01566.x.

Abstract

CD4+ CD25bright+ FoxP3+ T cells are potent regulators of T-cell reactivity, but their possible involvement in donor-specific nonresponsiveness after clinical kidney transplantation remains to be elucidated. We assessed the proliferative donor-reactivity in 33 kidney allograft recipients who were maintained on a combination of proliferation inhibitors (mycophenolate mofetil (MMF) or Azathioprine (Aza)) and prednisone, long (> 5 years) after transplantation. Of the 33 patients, 8 still exhibited donor-reactivity, whereas 25 were classified as donor nonreactive patients. Within these 25 donor nonreactive patients, we assessed the involvement of CD4+ CD25bright+ regulatory T cells both by depleting them from the responder population as well as by reconstituting them to the CD25(-/dim) effector population. The absence of proliferation in these 25 patients, was abolished in 7 (28%) recipients upon depletion of the CD4+ CD25bright+ T cells. Reconstitution of these cells suppressed the donor-reactivity in a dose-dependent manner. Adding-back CD4+ CD25bright+ T cells inhibited the anti-third party response in all recipients, indicating that functional CD4+ CD25bright+ T cells circulate despite more then 5 years of immunosuppressive treatment. Altogether, we conclude that in long-term immunosuppressed kidney allograft patients functional regulatory CD4+ CD25bright+ T cells circulate but that these cells mediate donor non reactivity only in a subset of patients.

摘要

CD4+ CD25bright+ FoxP3+ T细胞是T细胞反应性的有效调节因子,但其在临床肾移植后供体特异性无反应中的可能作用仍有待阐明。我们评估了33例肾移植受者的供体反应性增殖情况,这些受者在移植后长期(>5年)接受增殖抑制剂(霉酚酸酯(MMF)或硫唑嘌呤(Aza))和泼尼松联合治疗。在这33例患者中,8例仍表现出供体反应性,而25例被归类为供体无反应患者。在这25例供体无反应患者中,我们通过从反应细胞群中去除CD4+ CD25bright+调节性T细胞以及将它们重建到CD25(- / dim)效应细胞群中来评估其参与情况。在去除CD4+ CD25bright+ T细胞后,这25例患者中7例(28%)的增殖缺失被消除。这些细胞的重建以剂量依赖方式抑制了供体反应性。回输CD4+ CD25bright+ T细胞抑制了所有受者对第三方的反应,表明尽管经过了5年多的免疫抑制治疗,功能性CD4+ CD25bright+ T细胞仍在循环。总之,我们得出结论,在长期免疫抑制的肾移植患者中,功能性调节性CD4+ CD25bright+ T细胞在循环,但这些细胞仅在一部分患者中介导供体无反应性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验